He eventually got the rights back and licensed teplizumab to MacroGenics.
FORBES: Delaying Diabetes
2.
MacroGenics, of Rockville, Maryland, and its partner Eli Lilly just began a 500-patient trial with their drug teplizumab in recently diagnosed diabetic kids and adults up to age 35.
FORBES: Magazine Article
3.
MacroGenics, of Rockville, Maryland, and its partner Eli Lilly (nyse: LLY - news - people ) just began a 500-patient trial with their drug teplizumab in recently diagnosed diabetic kids and adults up to age 35.